Literature DB >> 29546995

Feasibility of using the Fitbit® Charge HR in validating self-reported exercise diaries in a community setting in patients with heart failure.

Pallav Deka1, Bunny Pozehl2, Joseph F Norman3, Deepak Khazanchi4.   

Abstract

BACKGROUND: Use of wrist-worn activity monitors has increased over the past few years; however, the use of the Fitbit® Charge HR (FCHR) in a community setting in patients with heart failure has not been tested.
PURPOSE: The purpose of the study was to assess the feasibility, practicality and acceptability of utilizing the FCHR to validate self-reported exercise diaries and monitor exercise in community dwelling patients with heart failure.
METHODS: Thirty heart failure patients (12 females and 18 males) aged 64.7 ± 11.5 years were provided with a FCHR. Participants were provided with an exercise routine and for eight weeks, recorded their exercise sessions in self-reported exercise diaries and used the FCHR to record those exercise sessions.
RESULTS: Exercise data from the self-reported exercise diaries were validated with data from the FCHR. Participants' perception and acceptance of using the FCHR was positive. Validation of exercise and physical activity interventions using the FCHR appears feasible and acceptable in patients with heart failure.
CONCLUSION: Wrist-worn activity monitors can be useful for objective measurement of exercise adherence and monitoring of physical activity in patients with heart failure in a community setting.

Entities:  

Keywords:  Fitbit; Heart failure; activity monitors; exercise adherence; self-report

Mesh:

Year:  2018        PMID: 29546995     DOI: 10.1177/1474515118766037

Source DB:  PubMed          Journal:  Eur J Cardiovasc Nurs        ISSN: 1474-5151            Impact factor:   3.908


  6 in total

1.  Comparing Real-Time Self-Tracking and Device-Recorded Exercise Data in Subjects with Type 1 Diabetes.

Authors:  Danielle Groat; Hyo Jung Kwon; Maria Adela Grando; Curtiss B Cook; Bithika Thompson
Journal:  Appl Clin Inform       Date:  2018-12-26       Impact factor: 2.342

2.  Is Fitbit Charge 2 a feasible instrument to monitor daily physical activity and handbike training in persons with spinal cord injury? A pilot study.

Authors:  M C Maijers; O Verschuren; J M Stolwijk-Swüste; C F van Koppenhagen; S de Groot; M W M Post
Journal:  Spinal Cord Ser Cases       Date:  2018-09-11

Review 3.  EVIDENCE Publication Checklist for Studies Evaluating Connected Sensor Technologies: Explanation and Elaboration.

Authors:  Christine Manta; Nikhil Mahadevan; Jessie Bakker; Simal Ozen Irmak; Elena Izmailova; Siyeon Park; Jiat-Ling Poon; Santosh Shevade; Sarah Valentine; Benjamin Vandendriessche; Courtney Webster; Jennifer C Goldsack
Journal:  Digit Biomark       Date:  2021-05-18

4.  An evidence-based structured one-year programme to sustain physical activity in patients with heart failure in primary care: A non-randomized longitudinal feasibility study.

Authors:  Lena Nordgren; Anne Söderlund
Journal:  Nurs Open       Date:  2020-05-15

5.  Measuring physical activity with activity monitors in patients with heart failure: from literature to practice. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology.

Authors:  Leonie Klompstra; Martha Kyriakou; Ekaterini Lambrinou; Massimo F Piepoli; Andrew J S Coats; Alain Cohen-Solal; Justien Cornelis; Barnabas Gellen; Elena Marques-Sule; David Niederseer; Francesco Orso; Ewa Piotrowicz; Emeline M Van Craenenbroeck; Maria Simonenko; Klaus K Witte; Anna Wozniak; Maurizio Volterrani; Tiny Jaarsma
Journal:  Eur J Heart Fail       Date:  2020-11-25       Impact factor: 15.534

Review 6.  Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature.

Authors:  Federico Germini; Noella Noronha; Victoria Borg Debono; Binu Abraham Philip; Drashti Pete; Tamara Navarro; Arun Keepanasseril; Sameer Parpia; Kerstin de Wit; Alfonso Iorio
Journal:  J Med Internet Res       Date:  2022-01-21       Impact factor: 5.428

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.